[The combined magnetoradiotherapy of breast cancer].
Preoperative magnetoradiation therapy of stage II-III breast cancer patients was followed by pronounced regression of tumor and axillary lymph node metastases in all cases. The treatment modality had been previously substantiated by establishing the optimal sequence and time intervals for magnetic and radiation fields. Complete regression of primary tumor and metastases verified by histologic and cytologic examination of surgical and biopsy material was observed in 20%. The best results were obtained for edematous-infiltrative form of cancer. In the control group (radiation alone), regression of tumor was only slight, nor did lymph node metastases regress. Magnetoradiation therapy did not involve either immediate or delayed adverse side-effects.
Akhmetov
E D
ED
Liu
B N
BN
Dzhamaldinov
D D
DD
Musin
T B
TB
Ismailov
B I
BI
D000230:Adenocarcinoma / Q000150:complications / Q000532:radiotherapy*; D000328:Adult; D000368:Aged; D001943:Breast Neoplasms / Q000150:complications / Q000532:radiotherapy*; D003131:Combined Modality Therapy; D006801:Humans; D008207:Lymphatic Metastasis; D008280:Magnetics / Q000009:adverse effects / Q000627:therapeutic use*; D008875:Middle Aged; D011300:Preoperative Care; D011878:Radiotherapy / Q000009:adverse effects; D011879:Radiotherapy Dosage; D012074:Remission Induction; D013997:Time Factors
Kombinirovannaia magnitoluchevaia terapiia raka molochnoĭ zhelezy.